e-learning
resources
ERJ
2001
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Aerosolized PGE1, PGI2 and nitroprusside protect against vascular leakage in lung ischaemia-reperfusion
Schutte H., Lockinger A., Seeger W., Grimminger F.
Source:
Eur Respir J 2001; 18: 15-22
Journal Issue:
July
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Schutte H., Lockinger A., Seeger W., Grimminger F.. Aerosolized PGE1, PGI2 and nitroprusside protect against vascular leakage in lung ischaemia-reperfusion. Eur Respir J 2001; 18: 15-22
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Inhaled vasodilators in acute lung injury
Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=129
Year: 2002
Methylene blue reduces pulmonary oedema and cyclo-oxygenase products in endotoxaemic sheep
Source: Eur Respir J 2002; 20: 957-964
Year: 2002
Intravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertension
Source: Eur Respir J 2002; 20: 339-343
Year: 2002
A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
Zardaverine and aerosolised iloprost in a model of acute respiratoryfailure
Source: Eur Respir J 2003; 22: 342-347
Year: 2003
Cardiopulmonary effects of iloprost in experimental acute lung injury
Source: Eur Respir J 2005; 25: 81-87
Year: 2005
Oestradiol ameliorates monocrotaline pulmonary hypertension via NO, prostacyclin and endothelin-1 pathways
Source: Eur Respir J 2013; 41: 1116-1125
Year: 2013
Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing
Source: Eur Respir J 2006; 27: 944-950
Year: 2006
Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction
Source: Eur Respir J 2003; 21: 19-24
Year: 2003
Inhaled sodium nitrite attenuates hypoxic pulmonary vasoconstriction
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008
Acetylcholine induces contractile and relaxant effects in canine nasal venous systems
Source: Eur Respir J 2006 Oct 01;28(4):839-846
Year: 2006
Hypoxia causes permeability oedema in the constant-pressure perfused rat lung
Source: Eur Respir J 2006; 27: 600-606
Year: 2006
Effects of prostacyclin analogous iloprost trometamol on bleomisin induced pulmonary fibrosis in rats
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
Oral administration of a new prostacyclin agonist with thromboxane synthase inhibitory activity improves bleomycin-induced lung fibrosis
Source: Annual Congress 2010 - New insights in the treatment of idiopathic pulmonary fibrosis
Year: 2010
Sildenafil enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 24s
Year: 2002
Esterification of iloprost enhances its protective effects on pulmonary endothelium
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
The new clinical trials on pharmacological treatment in pulmonary arterial hypertension
Source: Eur Respir J 2002; 20: 1037-1049
Year: 2002
Aerosolized iloprost induces a mild but sustained inhibition of platelet aggregation
Source: Eur Respir J 2002; 19: 518-524
Year: 2002
Differential action of beraprost isomers on prostacyclin (IP) receptors and PPARβ in pulmonary arteries
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury
Source: Eur Respir J 2013; 41: 165-176
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept